New Strategy for Antedrug Application: Development of Metalloproteinase Inhibitors as Antipsoriatic Drugs
Authors:
- 15 January 2002
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 45 (4) , 930-936
Abstract
Phosphonamide-based inhibitors were synthesized and evaluated for the inhibitory activities against the shedding of epidermal growth factors, amphiregulin and heparin-binding EGF-like growth factor, that would participate in the development of psoriasis. All compounds exhibited excellent inhibitory activities for these EGF sheddings; however, they also inhibited matrix metalloproteinases (MMPs). To avoid adverse effects reported by the clinical development of MMP inhibitors, the antedrug concept was introduced. Among the phosphonamide inhibitors, the 2,2,2-trifluoroethyl ester 8d and 2,2-difluoroethyl ester 8c showed rapid decomposition in human plasma, which is an essential property for the antedrug. Topical applications of these compounds significantly suppressed TPA-induced epidermal hyperplasia in murin skin, a model of psoriasis. These results suggested that the phosphonamide-based inhibitors have a therapeutic potential for the treatment of psoriasis as an antedrug application.Keywords
This publication has 19 references indexed in Scilit:
- Novel Glucocorticoid Antedrugs Possessing a 17β-(γ-Lactone) RingJournal of Medicinal Chemistry, 2001
- Therapeutic strategies for psoriasisJournal of Clinical Pharmacy and Therapeutics, 2000
- New drugs in the treatment of psoriasisExpert Opinion on Investigational Drugs, 2000
- Autocrine Regulation of Keratinocytes: The Emerging Role of Heparin-Binding, Epidermal Growth Factor-Related Growth FactorsJournal of Investigative Dermatology, 1998
- Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation In skin organ culture.Journal of Clinical Investigation, 1997
- New Steroidal Antiinflammatory Antedrugs: Steroidal [16.alpha.,17.alpha.-d]-3'-CarbethoxyisoxazolinesJournal of Medicinal Chemistry, 1995
- A Heparin-Binding Growth Factor Secreted by Macrophage-Like Cells That Is Related to EGFScience, 1991
- Structure and Function of Human Amphiregulin: A Member of the Epidermal Growth Factor FamilyScience, 1989
- Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7.Proceedings of the National Academy of Sciences, 1988
- Genetic Damage in Escherichia coli K12 AB2480 by Broad-spectrum Near-Ultraviolet RadiationScience, 1982